Evidence map›Paper›PMID 41634599›Full record

ArticleBMC infectious diseases2026

A multicenter point-prevalence survey of antibiotic utilization patterns in Ethiopia: implications for strengthening stewardship programs.

Mekonnen Damessa, Desta Assefa, Gemmechu Hasen, Belachew Umeta, Tsegaye Melaku, Geremew Kinati, Kedir Abdella Abdulsemed, Dereje Kebede, Habtewold Deti Waktola, Esayas Kebede Gudina and 1 more

Abstract readMulticenter Study
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mekonnen DamessaJimma University Laboratory of Drug Quality (JuLaDQ), Jimma, Oromia, Ethiopia. mekonnen.damessa@ju.edu.et.
Desta AssefaJimma University Laboratory of Drug Quality (JuLaDQ), Jimma, Oromia, Ethiopia.
Gemmechu HasenClinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Belachew UmetaJimma University Laboratory of Drug Quality (JuLaDQ), Jimma, Oromia, Ethiopia.
Tsegaye MelakuSchool of Pharmacy, Jimma University, Jimma, Oromia, Ethiopia.
Geremew KinatiJimma University Laboratory of Drug Quality (JuLaDQ), Jimma, Oromia, Ethiopia.
Kedir Abdella AbdulsemedDepartment of Medical Microbiology, School of Medical Laboratory, Jimma University, Jimma, Oromia, Ethiopia.
Dereje KebedeDepartment of Pharmacy, Adama Science and Technology University, Adama, Oromia, Ethiopia.
Habtewold Deti WaktolaJimma University Laboratory of Drug Quality (JuLaDQ), Jimma, Oromia, Ethiopia.
Esayas Kebede GudinaDepartment of Internal Medicine, School of Medicine, Jimma University, Jimma, Oromia, Ethiopia.
Sultan SulemanJimma University Laboratory of Drug Quality (JuLaDQ), Jimma, Oromia, Ethiopia. sultan.suleman@ju.edu.et.

Funding

Jimma University JUIH/IRB/716/23
6 · The paper itself

Abstract

backgroundThe emerging of antimicrobial resistant strains is destroying the paradigm-shifting power of antibiotics. The main driver of antimicrobial resistance inappropriate prescribing practices, primarily in institutions like Sub-Saharan Africa. Hence, this study aims to evaluate real antibiotic use patterns among inpatients at four public hospitals in Jimma, Ethiopia.

methodsAcross-sectional point prevalence survey using standardized World Health Organization (WHO)’s point-prevalence survey (PPS) was employed to conduct this study in August 2023. All hospitalized patients at adult and pediatric wards before or at 08:00 on the survey date were enrolled. Data collection tool was adopted and customized to collect hospital antibiotic use pattern using a standardized PPS method. Data were collected using Open Data Kit (ODK) and analyzed using SPSS version 27; where the p-value < 0.05 was considered statistically significant.

resultsA total of 344 patients were enrolled, with a male predominance (57.6%) and a majority (58.4%) aged over 18 years. The common clinical indications for antibiotic prescriptions were gastrointestinal infections (28.5%) followed by Respiratory tract (upper and lower) infections (27.4%). The antibiotics were mainly indicated for therapeutic purpose (59.3%). The antibiotic use prevalence was 85.8% with high rate (59.0%) of patients were receive “Watch” group antibiotics mainly from cephalosporin class. Empirical therapy was the predominant treatment approach (95.3%), with ceftriaxone being the most frequently prescribed agent, accounting for 43.3% of all empirical antibiotic use. Surgical prophylaxis accounted for the majority (88%) of prophylactic antibiotic use. Notably, nearly three-quarters (74%) of these patients received prophylaxis for longer than the recommended 24-hours. Only 4.0% of patients receiving parenteral antibiotics were switched to oral therapy. Furthermore, 37.1% of prescriptions deviated from guideline recommendations or lacked documentation to assess adherence. The treatment approach was rarely evidence-based, with microbiological testing absent in 90% of cases. Of patients who had culture results, gram-negative bacteria (e.g., E. coli, Klebsiella spp., Citrobacter spp.) were a common bacterial isolates. Multivariable analysis showed that surgical procedures (AOR = 5.96) and peripheral catheters (AOR = 6.81) were significantly associated with increased antibiotic use.

conclusionThe findings reveal alarmingly high antibiotic utilization in Ethiopian hospitals, primarily driven by excessive empirical prescribing, insufficient microbiological testing, and inappropriate and prolonged surgical prophylaxis. These results highlight the urgent need for multifaceted interventions, including strengthening diagnostic capabilities to support evidence-based prescribing, implementing robust antimicrobial stewardship programs with regular ward-level audits, and ensuring strict adherence to treatment guidelines.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipDrug UtilizationAdolescentAdultAgedChildChild, PreschoolCross-Sectional StudiesEthiopiaFemaleHumansMaleMiddle AgedPractice Patterns, Physicians'PrevalenceAnti-Bacterial AgentsThird Generation CephalosporinsAntibiotic utilizationAntimicrobial resistanceEmpirical prescribingEthiopiaPoint prevalence survey

Identifiers

PMID41634599
PMCPMC12958573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.